A PHARMACEUTICAL COMPOSITION FOR INHIBITION OF HELICOBACTER PYLORI GROWTH AND HELICOBACTER PYLORI-INDUCED INFLAMMATION IN HUMAN GASTRIC EPITHELIAL CELLS
The present invention relates to a pharmaceutical composition for inhibitingHelicobacter pyloriandH. pylori-induced inflammatory responses in gastric epithelial cells, which contains ovatodiolide compound and a pharmaceutically acceptable carrier.本發明係關於一種用於抑制幽門螺旋菌生長及抑制幽門螺旋菌誘導胃上皮細胞發炎反應之醫藥組合物,包含魚針草內酯(ovatodiolide)化合物或藥學上可接受的載體。